Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Mol Sci ; 18(6)2017 Jun 19.
Article in English | MEDLINE | ID: mdl-28629195

ABSTRACT

Members of Candida species cause significant health problems, inducing various types of superficial and deep-seated mycoses in humans. In order to prevent from Candida sp. development, essential oils are more and more frequently applied, due to their antifungal activity, low toxicity if used appropriately, and biodegrability. The aim of the study was to characterize the early alterations in Candida albicans metabolic properties in relation to proteins and chromosomal DNA profiles, after treatment with peppermint and clove oils at sub-inhibitory concentrations. The yeasts were affected by the oils even at a concentration of 0.0075% v/v, which resulted in changes in colony morphotypes and metabolic activities. Peppermint and clove oils at concentrations ranging from 0.015× MIC (minimal inhibitory concentration) to 0.5× MIC values substantially affected the enzymatic abilities of C. albicans, and these changes were primarily associated with the loss or decrease of activity of all 9 enzymes detected in the untreated yeast. Moreover, 29% isolates showed additional activity of N-acetyl-ß-glucosaminidase and 14% isolates-α-fucosidase in comparison to the yeast grown without essential oils addition. In response to essential oils at 0.25-0.5× MIC, extensive changes in C. albicans whole-cell protein profiles were noted. However, the yeast biochemical profiles were intact with the sole exception of the isolate treated with clove oil at 0.5× MIC. The alterations were not attributed to gross chromosomal rearrangements in C. albicans karyotype. The predominantly observed decrease in protein fractions and the yeast enzymatic activity after treatment with the oils should be considered as a phenotypic response of C. albicans to the essential oils at their sub-inhibitory concentrations and may lead to the reduction of this yeast pathogenicity.


Subject(s)
Antifungal Agents/pharmacology , Candida albicans/drug effects , Candida albicans/metabolism , Clove Oil/pharmacology , Mentha piperita/chemistry , Plant Extracts/pharmacology , Plant Oils/pharmacology , Antifungal Agents/chemistry , Candida albicans/enzymology , Candida albicans/growth & development , Chromosomes, Fungal/drug effects , Clove Oil/chemistry , Enzyme Assays , Fungal Proteins/drug effects , Fungal Proteins/metabolism , Hexosaminidases/drug effects , Humans , Karyotype , Microbial Sensitivity Tests , Molecular Weight , Oils, Volatile , Plant Extracts/chemistry , Plant Oils/chemistry , alpha-L-Fucosidase/drug effects
2.
J Nat Prod ; 70(6): 993-7, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17536859

ABSTRACT

An examination of the bulbs of Scilla socialis has resulted in the isolation of 11 hyacinthacines, two pyrrolidines, and three piperidines. The structures of the new alkaloids were elucidated by spectroscopic methods as beta-1-C-ethyldeoxymannojirimycin (5), hyacinthacines B7 (10), C2 (11), C3 (12), C4 (13), and C5 (14), and alpha-5-C-(3-hydroxybutyl)hyacinthacine A2 (15). Although, beta-l-homofuconojirimycin (3) and alpha-7-deoxyhomonojirimycin (alpha-7-deoxy-HNJ, 4) are previously known alkaloids, this is the first report of their occurrence in the plant family Hyacinthaceae. Alkaloid 11 was found to be a good inhibitor of bacterial beta-glucosidase and human placenta alpha-l-fucosidase, with IC50 values of 13 and 17 microM, respectively, while alkaloid 12 showed no inhibitory activity toward alpha-l-fucosidase but was a more potent inhibitor of bovine liver beta-galactosidase (IC50 = 52 microM) than 11. Alkaloids 13 and 14 were shown to be inhibitory toward mammalian alpha-glucosidase (IC50 = 45 and 77 microM, respectively), and alkaloid 14 was demonstrated as a moderate inhibitor of bacterial beta-glucosidase (IC50 = 48 microM).


Subject(s)
Glycoside Hydrolases/antagonists & inhibitors , Piperidines/isolation & purification , Piperidines/pharmacology , Plants, Medicinal/chemistry , Pyrrolizidine Alkaloids/isolation & purification , Pyrrolizidine Alkaloids/pharmacology , Scilla/chemistry , Animals , Aspergillus niger/enzymology , Cattle , Glucan 1,4-alpha-Glucosidase/drug effects , Humans , Liver/enzymology , Molecular Structure , Oryza/enzymology , Piperidines/chemistry , Placenta/enzymology , Pyrrolizidine Alkaloids/chemistry , Rats , Yeasts/enzymology , alpha-Galactosidase/drug effects , alpha-Glucosidases/drug effects , alpha-L-Fucosidase/drug effects , alpha-Mannosidase/drug effects
3.
Clin Chim Acta ; 255(2): 173-81, 1996 Nov 29.
Article in English | MEDLINE | ID: mdl-8937760

ABSTRACT

The activities of eight lysosomal enzymes were measured by spectrophotometric/spectrofluorimetric techniques in the blood sera of 19-24 apparently healthy women using an oral contraceptive (progestin and oestradiol synthetic derivative, desogestrel+ethinyloestradiol) in comparison with 15-16 non-pregnant women not using contraceptives (controls), in a randomised, double-blind, controlled study. beta-Glucuronidase and arylesterase showed statistically increased activities (P < or = 0.05) in the experimental group in comparison to the controls. No significant differences were found for the remaining enzymes assayed (beta-N-acetylhexosaminidase, alpha-L-fucosidase, alpha-mannosidase, beta-galactosidase, alpha-galactosidase and acid phosphatase). Similar results were obtained when the contraceptive formed by the combination of levonorgestrel and ethinyloestradiol was used by an experimental group of eight healthy women. These results suggest that the significant increases in the above-mentioned activities might be the physiological response of the organism (through catabolic processes catalysed by lysosomal enzymes) to the administration of exogenous synthetic compounds, such as the oral contraceptives used.


Subject(s)
Contraceptives, Oral/pharmacology , Lysosomes/enzymology , Acetylglucosaminidase/blood , Acetylglucosaminidase/drug effects , Acetylglucosaminidase/metabolism , Acid Phosphatase/blood , Acid Phosphatase/drug effects , Acid Phosphatase/metabolism , Adult , Carboxylic Ester Hydrolases/blood , Carboxylic Ester Hydrolases/drug effects , Carboxylic Ester Hydrolases/metabolism , Female , Glucuronidase/blood , Glucuronidase/drug effects , Glucuronidase/metabolism , Humans , Mannosidases/blood , Mannosidases/drug effects , Mannosidases/metabolism , alpha-L-Fucosidase/blood , alpha-L-Fucosidase/drug effects , alpha-L-Fucosidase/metabolism , alpha-Mannosidase , beta-Galactosidase/blood , beta-Galactosidase/drug effects , beta-Galactosidase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...